Researchers have developed a new type of sensor that acts like Velcro® for prostate cancer cells, sticking them to a modified frosted glass slide, like those used in science classes, so that they can be identified from blood samples. The low-cost method, reported in ACS Applied Materials & Interfaces, could help doctors better diagnose and monitor the disease.
In men with prostate cancer, some tumor cells exit the prostate gland and circulate in the blood. Detecting these cells could enable diagnosis at an earlier stage or help doctors assess whether treatment is effective. However, because circulating tumor cells are present in very small numbers, finding them can be a challenge. Previous sensors have been expensive and difficult to make. So Shudong Zhang and Shutao Wang wanted do develop a simpler, more cost-effective way to monitor prostate cancer cells in the blood.
The researchers based their device on frosted glass microscope slides, commonplace in high school science classes. The frosted area, which is used to hold and label the slide, is a sandblasted surface with tiny depressions. The researchers added a solution to the frosted slides that caused silica nanowires to grow on their surfaces, then they dangled antibodies that recognized prostate cancer cells from the nanowires. After getting captured by the antibodies, circulating tumor cells became trapped in the depressions on the slide and tangled up within the nanowires, similar to the interlocking surfaces of Velcro®. The team could then visualize the cancer cells with microscopy, and found that the device had a capture efficiency on par with other approaches, they say. When the researchers tested blood samples from prostate cancer patients, the devices detected as few as 10 tumor cells in 1 milliliter of blood.
Receive an email update when we add a new PROSTATE CANCER article.
The Latest on: Prostate cancer
via Google News
The Latest on: Prostate cancer
Man’s risk of prostate cancer linked to inflammatory bowel disease
on December 16, 2018 at 11:21 pm
New United States research has found a link between inflammatory bowel disease and an increased risk of being diagnosed with prostate cancer. Carried out by researchers at Northwestern University ... […]
KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer.
on December 16, 2018 at 11:00 pm
There is a considerable need to identify those individuals with prostate cancer who have indolent disease. We propose that genes that control adult stem cell homeostasis in organs with slow turnover, ... […]
New computer model helps predict course of the disease in prostate cancer patients
on December 14, 2018 at 8:09 pm
How does a normal cell turn into a deadly cancer? Seeking an answer to this question, and working alongside other international working groups, researchers from Charité - Universitätsmedizin Berlin ex... […]
Non-invasive MRI Scan to Reduce Prostate Cancer Biopsies
on December 14, 2018 at 2:35 pm
The National Institute for Health and Care Excellence (NICE) recommended an MRI scan as a first-line investigation for men with suspected clinically localised prostate cancer. It said imaging could he... […]
Crohn's, colitis may increase prostate cancer risk
on December 14, 2018 at 11:52 am
FRIDAY, Dec. 14, 2018 -- Men with inflammatory bowel disease have a significantly greater risk of prostate cancer, a new study finds. About 1 million men in the United States have inflammatory bowel d... […]
Prostate cancer: New computer model enables researchers to predict course of disease
on December 14, 2018 at 9:10 am
How does a normal cell turn into a deadly cancer? Seeking an answer to this Question researchers examined the tumor genomes of nearly 300 prostate cancer patients. Their findings describe the ways in ... […]
IBD increases prostate cancer risk by fivefold
on December 14, 2018 at 8:15 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current lis... […]
Pat Benatar Performs At Prostate Cancer Foundation 2018 New York Dinner
on December 14, 2018 at 7:30 am
The Prostate Cancer Foundation (PCF) hosted the 2018 New York Dinner at the Restaurant Daniel at 60 East 65th Street in New York City and raised $11 million dollars to support the foundation. Pat Bena... […]
Surgery unnecessary for many prostate cancer patients
on December 13, 2018 at 4:57 am
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery ... […]
via Bing News